$1.17
(Market cap
$513 Mln
Revenue (TTM)
$546 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-6.5 %
-
ROCE
-- %
-
Industry P/E
33.16
-
EV/EBITDA
8.5
-
Debt to Equity
-4.8
-
Book Value
$--
-
EPS
$-0
-
Face value
--
-
Shares outstanding
99,982,933
6 Years Aggregate
CFO
$-120.99 Mln
EBITDA
$-167.75 Mln
Net Profit
$-91.54 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
| 74.2 | 5.3 | 55.0 | 44.9 | 91.0 | -9.0 | -- |
|
BSE Sensex*
| -11.7 | -4.8 | 1.1 | -7.8 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
| 1,052.1 | -84.6 | 23.6 | -83.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
|
6.2 | 512.9 | 545.8 | -43.5 | -6.6 | -- | -- | 0.8 |
| 518.6 | 6,794.3 | 2,595.0 | 275.0 | 14.1 | 30.4 | 26.1 | 8.2 | |
| 121.5 | 12,015.0 | 6,206.1 | 621.0 | 18.6 | 16.2 | 20.3 | 4.6 | |
| 27.9 | 6,490.8 | 2,578.1 | -142.0 | -6.3 | -32.8 | -- | 20.5 | |
| 12.6 | 4,863.6 | 1,584.8 | 50.6 | 4.9 | 3.4 | 97.9 | 3.3 | |
| 227.2 | 3,471.2 | 1,559.0 | 140.3 | 12.1 | 12.6 | 24.9 | 3.1 | |
| 49.8 | 4,147.5 | 1,003.0 | -24.3 | 5.5 | -2.1 | 292.8 | 1.5 | |
| 70.9 | 5,800.8 | 2,268.9 | -21.1 | 4.7 | -5.6 | -- | 5.4 | |
| 18.3 | 5,393.6 | 1,216.2 | 163.5 | 33.5 | 25.7 | 33.2 | 8.2 | |
| 171.8 | 9,954.1 | 5,486.7 | 378.7 | 9.2 | 16.2 | 26.8 | 4.1 |
Shareholding Pattern
View DetailsAbout Oncology Institute Inc (TOI)
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services,... in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Read more
-
Executive Chairman of the Board
Mr. Richard Alan Barasch
-
Executive Chairman of the Board
Mr. Richard Alan Barasch
-
Headquarters
Cerritos, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Oncology Institute Inc (TOI)
What is the current share price of Oncology Institute Inc (TOI) Today?
The share price of Oncology Institute Inc (TOI) is $6.20 (NASDAQ) as of 11-Aug-2026 09:30 EDT. Oncology Institute Inc (TOI) has given a return of 90.99% in the last 3 years.
What is the current PB & PE ratio of Oncology Institute Inc (TOI)?
Since, TTM earnings of Oncology Institute Inc (TOI) is negative, P/E ratio is not available.
The P/B ratio of Oncology Institute Inc (TOI) is 0.76 times as on 11-Aug-2026, a 79 discount to its peers’ median range of 3.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-59.60 |
-229.76 |
2024 |
-0.36 |
6.51 |
2023 |
-1.80 |
2.63 |
2022 |
929.12 |
1.15 |
2021 |
-62.42 |
6.55 |
What is the 52 Week High and Low of Oncology Institute Inc (TOI)?
The 52-week high and low of Oncology Institute Inc (TOI) are Rs 6.66 and Rs 2.32 as of 10-Sep-2026.
What is the market cap of Oncology Institute Inc (TOI)?
Oncology Institute Inc (TOI) has a market capitalisation of $ 513 Mln as on 11-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Oncology Institute Inc (TOI)?
Before investing in Oncology Institute Inc (TOI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.